financetom
Business
financetom
/
Business
/
Waymo's autonomous ride-hailing service now available to all in San Francisco
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Waymo's autonomous ride-hailing service now available to all in San Francisco
Jun 25, 2024 10:52 AM

(Reuters) - Alphabet's Waymo said on Tuesday its autonomous ride-hailing service, Waymo One, is now available to everyone in San Francisco, nearly four years after a similar move in Phoenix, Arizona.

Driverless vehicles are expected to drive commercial success for automakers even as regulatory scrutiny remains tight amid concerns of investors about growing investments in the nascent technology.

Waymo had started a test service with its research-focused program in San Francisco in 2021, which included an autonomous specialist on board for all rides at that time, as it looked to commercialize the technology.

The company said that about 300,000 people had signed up to ride with Waymo since it first opened a waitlist in the city, signaling strong demand. Now with open access, anyone can request a ride on its app.

The company had opened access to everyone in Phoenix, Arizona without a waitlist in 2020.

Mountain View, California-based Waymo is a self-driving technology pioneer, which started its first U.S. driverless taxi service in 2020 over a decade after it was born in 2009 as a project inside Google.

In March, the company received approval from the California Public Utilities Commission (CPUC) to start its Waymo One in Los Angeles and some cities near San Francisco.

Rivals including General Motors-backed Cruise and Amazon.com's Zoox are accelerating a race to succeed amid probes by auto regulators involving the performance of autonomous driving cars.

Last month, the U.S. National Highway Traffic Safety Administration said it had learned of nine additional incidents raising concerns about the performance of Waymo self-driving vehicles.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-United States Steel Continues To Recommend Shareholders Vote
BRIEF-United States Steel Continues To Recommend Shareholders Vote "For" Proposals To Be Voted At Special Meeting Including Merger Deal With Nippon Steel
Apr 2, 2024
April 2 (Reuters) - United States Steel Corp ( X ): * UNITED STATES STEEL ( X )- CONTINUES TO RECOMMEND SHAREHOLDERS VOTE FOR PROPOSALS TO BE VOTED AT SPECIAL MEETING INCLUDING MERGER DEAL WITH NIPPON STEEL Source text for Eikon: Further company coverage: ...
I-Mab Completes Business Divestiture in China
I-Mab Completes Business Divestiture in China
Apr 2, 2024
04:41 PM EDT, 04/02/2024 (MT Newswires) -- I-Mab ( IMAB ) said late Tuesday it closed 100% divestiture of its China business, I-Mab Biopharma, to I-Mab Biopharma (Hangzhou) for an equivalent of up to $80 million. The deal is, however, contingent on the I-Mab Biopharma (Hangzhou)'s achievement of regulatory and sales-based milestones. At the same time, I-Mab ( IMAB )...
Review board to issue report detailing Microsoft's lapses in China hack, Washington Post says
Review board to issue report detailing Microsoft's lapses in China hack, Washington Post says
Apr 2, 2024
April 2 (Reuters) - The Cyber Safety Review Board is expected to issue a report detailing lapses by the tech giant Microsoft ( MSFT ) that led to a targeted Chinese hack of top U.S. government officials' emails last year, the Washington Post reported on Tuesday. (Reporting by Mehnaz Yasmin in Bengaluru) ...
BRIEF-Medirom Healthcare Technologies Entered Into A MOU For Purpose Of Acquiring All Shares Of Stock Of Japan Gene Medicine Corporation
BRIEF-Medirom Healthcare Technologies Entered Into A MOU For Purpose Of Acquiring All Shares Of Stock Of Japan Gene Medicine Corporation
Apr 2, 2024
April 2 (Reuters) - Medirom Healthcare Technologies Inc ( MRM ) : * MEDIROM HEALTHCARE TECHNOLOGIES INC ( MRM ) - ENTERED INTO A MOU FOR PURPOSE OF ACQUIRING ALL SHARES OF STOCK OF JAPAN GENE MEDICINE CORPORATION * MEDIROM HEALTHCARE TECHNOLOGIES INC ( MRM ) - PROPOSED DEAL FOR TOTAL PRICE OF 2.4 BILLION YEN Source text for Eikon:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved